Related Experiment Video
Updated: Nov 5, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
The genetic and epigenetic basis of distinct melanoma types
1Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Abstract:
Melanoma represents the deadliest skin cancer. Recent therapeutic developments, including targeted and immune therapies have revolutionized clinical management and improved patient outcome. This progress was achieved by rigorous molecular and functional studies followed by robust clinical trials. The identification of key genomic alterations and gene expression profiles have propelled the understanding of distinct characteristics within melanoma subtypes. The aim of this review is to summarize and highlight the main genetic and epigenetic findings of melanomas and highlight their pathological and therapeutic importance.
Insights
Melanoma, the deadliest skin cancer, has seen improved outcomes due to targeted and immune therapies. This review highlights key genetic and epigenetic findings crucial for understanding melanoma subtypes and guiding treatment.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Melanoma is the most lethal form of skin cancer.
- Recent advances in targeted and immune therapies have significantly improved patient prognosis.
- Progress relies on deep molecular and functional understanding, validated by clinical trials.
Purpose of the Study:
- To review and synthesize major genetic and epigenetic discoveries in melanoma.
- To emphasize the pathological and therapeutic significance of these findings.
- To provide an updated overview for researchers and clinicians.
Main Methods:
- Literature review of recent studies on melanoma genetics and epigenetics.
- Analysis of genomic alterations and gene expression profiles.
- Synthesis of findings related to melanoma subtypes and therapeutic implications.
Main Results:
- Identification of key genomic alterations driving melanoma development and progression.
- Characterization of distinct gene expression profiles across melanoma subtypes.
- Correlation of molecular findings with therapeutic responses and clinical outcomes.
Conclusions:
- Genetic and epigenetic alterations are fundamental to melanoma biology.
- Understanding these alterations is critical for developing effective targeted and immune therapies.
- Continued research into melanoma's molecular landscape will further refine patient management and improve survival rates.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancers Originate from Somatic Mutations in a Single Cell
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

